Logo image of RCT.CA

ROCHESTER RESOURCES LTD (RCT.CA) Stock Fundamental Analysis

TSX-V:RCT - TSX Venture Exchange - CA77174P3007 - Common Stock - Currency: CAD

0.015  -0.01 (-25%)

Fundamental Rating

2

Overall RCT gets a fundamental rating of 2 out of 10. We evaluated RCT against 822 industry peers in the Metals & Mining industry. RCT has a bad profitability rating. Also its financial health evaluation is rather negative. RCT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RCT had negative earnings in the past year.
RCT had a positive operating cash flow in the past year.
RCT had negative earnings in 4 of the past 5 years.
Each year in the past 5 years RCT had a positive operating cash flow.
RCT.CA Yearly Net Income VS EBIT VS OCF VS FCFRCT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

RCT has a Return On Assets of -51.60%. This is in the lower half of the industry: RCT underperforms 62.42% of its industry peers.
Industry RankSector Rank
ROA -51.6%
ROE N/A
ROIC N/A
ROA(3y)-77.49%
ROA(5y)-51.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCT.CA Yearly ROA, ROE, ROICRCT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCT.CA Yearly Profit, Operating, Gross MarginsRCT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

RCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RCT has about the same amount of shares outstanding.
The number of shares outstanding for RCT has been increased compared to 5 years ago.
RCT has a worse debt/assets ratio than last year.
RCT.CA Yearly Shares OutstandingRCT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
RCT.CA Yearly Total Debt VS Total AssetsRCT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -21.56, we must say that RCT is in the distress zone and has some risk of bankruptcy.
RCT has a Altman-Z score of -21.56. This is in the lower half of the industry: RCT underperforms 75.03% of its industry peers.
RCT has a debt to FCF ratio of 11.11. This is a negative value and a sign of low solvency as RCT would need 11.11 years to pay back of all of its debts.
RCT's Debt to FCF ratio of 11.11 is amongst the best of the industry. RCT outperforms 91.03% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.11
Altman-Z -21.56
ROIC/WACCN/A
WACC4%
RCT.CA Yearly LT Debt VS Equity VS FCFRCT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

2.3 Liquidity

RCT has a Current Ratio of 0.25. This is a bad value and indicates that RCT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of RCT (0.25) is worse than 72.97% of its industry peers.
A Quick Ratio of 0.21 indicates that RCT may have some problems paying its short term obligations.
RCT has a Quick ratio of 0.21. This is in the lower half of the industry: RCT underperforms 73.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.21
RCT.CA Yearly Current Assets VS Current LiabilitesRCT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.51% over the past year.
Looking at the last year, RCT shows a very negative growth in Revenue. The Revenue has decreased by -13.30% in the last year.
RCT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.69% yearly.
EPS 1Y (TTM)28.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.48%
Revenue 1Y (TTM)-13.3%
Revenue growth 3Y-0.83%
Revenue growth 5Y12.69%
Sales Q2Q%-6.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCT.CA Yearly Revenue VS EstimatesRCT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
RCT.CA Yearly EPS VS EstimatesRCT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

RCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCT.CA Price Earnings VS Forward Price EarningsRCT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than RCT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.37
EV/EBITDA N/A
RCT.CA Per share dataRCT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RCT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCHESTER RESOURCES LTD

TSX-V:RCT (3/7/2025, 7:00:00 PM)

0.015

-0.01 (-25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)01-26 2022-01-26
Inst Owners2.85%
Inst Owner ChangeN/A
Ins Owners59.75%
Ins Owner ChangeN/A
Market Cap707.10K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 0.37
P/OCF 0.23
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY273.07%
OCF(TTM)0.06
OCFY431.07%
SpS0.26
BVpS-0.72
TBVpS-0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 15.89%
ROA(3y)-77.49%
ROA(5y)-51.01%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.11
Debt/EBITDA N/A
Cap/Depr 225.2%
Cap/Sales 9.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.21
Altman-Z -21.56
F-Score3
WACC4%
ROIC/WACCN/A
Cap/Depr(3y)98.13%
Cap/Depr(5y)156.65%
Cap/Sales(3y)4.04%
Cap/Sales(5y)4.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.3%
Revenue growth 3Y-0.83%
Revenue growth 5Y12.69%
Sales Q2Q%-6.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1061.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y864.59%
OCF growth 3Y-27.62%
OCF growth 5YN/A